Methods and compositions for the treatment of neurological disease

Details for Australian Patent Application No. 2004281764 (hide)

Owner Neurologix Research, Inc.

Inventors Vezzani, Annamaria; During, Matthew J.

Agent Madderns

Pub. Number AU-B-2004281764

PCT Pub. Number WO2005/037211

Priority 60/573,082 21.05.04 US; 60/510,985 14.10.03 US

Filing date 14 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 7 April 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12N 15/864 (2006.01) Mutation or genetic engineering - Parvoviral vectors

C12N 15/867 (2006.01) Mutation or genetic engineering - Retroviral vectors

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/037211 Priority application(s): WO2005/037211

7 April 2011 Application Accepted

  Published as AU-B-2004281764

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281766-Enhancing transdermal administration of hydrophilic drugs

2004281759-Sterilization wraps and methods for sterilizing articles